Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma

Modern Pathology

Volumn 21, Issue 2, 2008, Pages 105-114

  Prasad, Manju L ^a,c   Barbacioru, Catalin C ^b   Rawal, Yeshwant B ^a   Husein, Omar ^a   Wen, Ping ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b APPLIED BIOSYSTEMS   (United States)

^c UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Adenoid cystic carcinoma; Calponin; Immunohistochemistry; Maspin; Metallothionein; p63; Polymorphous low grade adenocarcinoma

Indexed keywords

CALPONIN; MASPIN; METALLOTHIONEIN; MYOSIN HEAVY CHAIN; PROTEIN P63; SMOOTH MUSCLE ACTIN;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; BASAL CELL; CANCER GRADING; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MYOEPITHELIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOID CYSTIC; CLUSTER ANALYSIS; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MALE; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS, MINOR; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 38649135101     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800983     Document Type: Article

References (29)

1. Castle JT, Thompson LD, Frommelt RA, et al. Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases. Cancer 1999;86:207-219.
2. Beltran D, Faquin WC, Gallagher G, et al. Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma. J Oral Maxillofac Surg 2006;64:415-423.
3. Edwards PC, Bhuiya T, Kelsch RD. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:613-619.
4. Penner CR, Folpe AL, Budnick SD. C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Mod Pathol 2002;15:687-691.
5. Cherian MG, Jayasurya A, Bay B-H. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 2003;533:201-209.
6. Jin R, Bay BH, Chow VT, et al. Significance of metallothionein expression in breast myoepithelial cells. Cell Tissue Res 2001;303:221-226.
7. Cherian MG. The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells. Environ Health Perspect 1994;102(Suppl 3):131-135.
8. Nartey N, Cherian MG, Banerjee D. Immunohistochemical localization of metallothionein in human thyroid tumors. Am J Pathol 1987;129:177-182.
9. Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994;263:526-529.
10. Zarbo RJ, Prasad AR, Regezi JA, et al. Salivary gland basal cell and canalicular adenomas: immunohistochemical demonstration of myoepithelial cell participation and morphogenetic considerations. Arch Pathol Lab Med 2000;124:401-405.
11. Prasad AR, Savera AT, Gown AM, et al. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Arch Pathol Lab Med 1999;123:801-806.
12. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus - associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006;24:736-747.
13. Luna MA, Wenig BM. Polymorphous low-grade adenocarcinoma. In: Barnes L, Eveson JW, Reichart P, Sidransky D (eds). World Health Organization Classification of Tumors: Pathology and Genetics of Head and Neck Tumors. IARC Press: Lyon, France, 2005, pp 223-224.
14. Peel R. Diseases of the salivary glands. In: Barnes L (ed). Surgical Pathology of the Head and Neck, 2nd edn. M. Dekker: New York, NY, 2001, pp 699-701.
15. da Cruz Perez DE, de Abreu Alves F, Nobuko Nishimoto I, et al. Prognostic factors in head and neck adenoid cystic carcinoma. Oral Oncol 2006;42:139-146.
16. Chen JC, Gnepp DR, Bedrossian CW. Adenoid cystic carcinoma of the salivary glands: an immunohistochemical analysis. Oral Surg Oral Med Oral Pathol 1988;65:316-326.
17. Perez-Ordonez B, Linkov I, Huvos AG. Polymorphous low-grade adenocarcinoma of minor salivary glands: a study of 17 cases with emphasis on cell differentiation. Histopathology 1998;32:521-529.
18. Gnepp DR, Chen JC, Warren C. Polymorphous low-grade adenocarcinoma of minor salivary gland. An immunohistochemical and clinicopathologic study. Am J Surg Pathol 1988;12:461-468.
19. Regezi JA, Zarbo RJ, Stewart JC, et al. Polymorphous low-grade adenocarcinoma of minor salivary gland. A comparative histologic and immunohistochemical study. Oral Surg Oral Med Oral Pathol 1991;71:469-475.
20. Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8:494-501.
21. Norberg LE, Burford-Mason AP, Dardick I. Cellular differentiation and morphologic heterogeneity in polymorphous low-grade adenocarcinoma of minor salivary gland. J Oral Pathol Med 1991;20:373-379.
22. Anderson C, Krutchkoff D, Pedersen C, et al. Polymorphous low grade adenocarcinoma of minor salivary gland: a clinicopathologic and comparative immunohistochemical study. Mod Pathol 1990;3:76-82.
23. Hsu FD, Nielsen TO, Alkushi A, et al. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol 2002;15:1374-1380.
24. Au NHC, Cheang M, Huntsman DG, et al. Evaluation of immunohistochemical markers in non small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers. J Pathol 2004;204:101-109.
25. Olsen SH, Thomas DG, Lucas DR. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Mod Pathol 2006;19:659-668.
26. Zhang W, Hart J, McLeod HL, et al. Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms. Am J Clin Pathol 2005;124:11-19.
27. Bozcuk H, Gumus A, Ozbilim G, et al. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non small cell lung cancer. Med Sci Monit 2005;11:HY11-HY20.
28. Lyall MS, Dundas SR, Curran S, et al. Profiling markers of prognosis in colorectal cancer. Clin Cancer Res 2006;12:1184-1191.
29. Makretsov NA, Huntsman DG, Nielsen TO, et al. Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma. Clin Cancer Res 2004;10:6143-6151.